These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32616561)

  • 1. Disease-associated keratin mutations reduce traction forces and compromise adhesion and collective migration.
    Fujiwara S; Deguchi S; Magin TM
    J Cell Sci; 2020 Jul; 133(14):. PubMed ID: 32616561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional testing of keratin 14 mutant proteins associated with the three major subtypes of epidermolysis bullosa simplex.
    Sørensen CB; Andresen BS; Jensen UB; Jensen TG; Jensen PK; Gregersen N; Bolund L
    Exp Dermatol; 2003 Aug; 12(4):472-9. PubMed ID: 12930305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct Impact of Two Keratin Mutations Causing Epidermolysis Bullosa Simplex on Keratinocyte Adhesion and Stiffness.
    Homberg M; Ramms L; Schwarz N; Dreissen G; Leube RE; Merkel R; Hoffmann B; Magin TM
    J Invest Dermatol; 2015 Oct; 135(10):2437-2445. PubMed ID: 25961909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cell-based drug discovery assay identifies inhibition of cell stress responses as a new approach to treatment of epidermolysis bullosa simplex.
    Tan TS; Common JEA; Lim JSY; Badowski C; Firdaus MJ; Leonardi SS; Lane EB
    J Cell Sci; 2021 Oct; 134(19):. PubMed ID: 34643242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and characterization of epidermolysis bullosa simplex cell lines: scratch assays show faster migration with disruptive keratin mutations.
    Morley SM; D'Alessandro M; Sexton C; Rugg EL; Navsaria H; Shemanko CS; Huber M; Hohl D; Heagerty AI; Leigh IM; Lane EB
    Br J Dermatol; 2003 Jul; 149(1):46-58. PubMed ID: 12890194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Drosophila Model of Epidermolysis Bullosa Simplex.
    Bohnekamp J; Cryderman DE; Paululat A; Baccam GC; Wallrath LL; Magin TM
    J Invest Dermatol; 2015 Aug; 135(8):2031-2039. PubMed ID: 25830653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of immortalized human epidermolysis bullosa simplex (KRT5) cell lines: trimethylamine N-oxide protects the keratin cytoskeleton against disruptive stress condition.
    Chamcheu JC; Lorié EP; Akgul B; Bannbers E; Virtanen M; Gammon L; Moustakas A; Navsaria H; Vahlquist A; Törmä H
    J Dermatol Sci; 2009 Mar; 53(3):198-206. PubMed ID: 19157792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the non-helical linker segment L1-2 of keratin 5 in patients with Weber-Cockayne epidermolysis bullosa simplex.
    Chan YM; Yu QC; LeBlanc-Straceski J; Christiano A; Pulkkinen L; Kucherlapati RS; Uitto J; Fuchs E
    J Cell Sci; 1994 Apr; 107 ( Pt 4)():765-74. PubMed ID: 7520042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel and recurrent mutations in keratin KRT5 and KRT14 genes in epidermolysis bullosa simplex: implications for disease phenotype and keratin filament assembly.
    Müller FB; Küster W; Wodecki K; Almeida H; Bruckner-Tuderman L; Krieg T; Korge BP; Arin MJ
    Hum Mutat; 2006 Jul; 27(7):719-20. PubMed ID: 16786515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperature sensitivity of the keratin cytoskeleton and delayed spreading of keratinocyte lines derived from EBS patients.
    Morley SM; Dundas SR; James JL; Gupta T; Brown RA; Sexton CJ; Navsaria HA; Leigh IM; Lane EB
    J Cell Sci; 1995 Nov; 108 ( Pt 11)():3463-71. PubMed ID: 8586658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratin mutations in patients with epidermolysis bullosa simplex: correlations between phenotype severity and disturbance of intermediate filament molecular structure.
    Jerábková B; Marek J; Bucková H; Kopecková L; Veselý K; Valícková J; Fajkus J; Fajkusová L
    Br J Dermatol; 2010 May; 162(5):1004-13. PubMed ID: 20030639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinase Inhibition by PKC412 Prevents Epithelial Sheet Damage in Autosomal Dominant Epidermolysis Bullosa Simplex through Keratin and Cell Contact Stabilization.
    Rietscher K; Jahnke HG; Rübsam M; Lin EW; Has C; Omary MB; Niessen CM; Magin TM
    J Invest Dermatol; 2022 Dec; 142(12):3282-3293. PubMed ID: 35691363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supplementation of a mutant keratin by stable expression of desmin in cultured human EBS keratinocytes.
    Magin TM; Kaiser HW; Leitgeb S; Grund C; Leigh IM; Morley SM; Lane EB
    J Cell Sci; 2000 Dec; 113 Pt 23():4231-9. PubMed ID: 11069768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel keratin 14 gene mutations in patients from Hungary with epidermolysis bullosa simplex.
    Csikós M; Szalai Z; Becker K; Sebõk B; Schneider I; Horváth A; Kárpáti S
    Exp Dermatol; 2004 Mar; 13(3):185-91. PubMed ID: 14987259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermolysis bullosa simplex: recurrent and de novo mutations in the KRT5 and KRT14 genes, phenotype/genotype correlations, and implications for genetic counseling and prenatal diagnosis.
    Pfendner EG; Sadowski SG; Uitto J
    J Invest Dermatol; 2005 Aug; 125(2):239-43. PubMed ID: 16098032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines as genetic modifiers in K5-/- mice and in human epidermolysis bullosa simplex.
    Roth W; Reuter U; Wohlenberg C; Bruckner-Tuderman L; Magin TM
    Hum Mutat; 2009 May; 30(5):832-41. PubMed ID: 19267394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of keratinocytes with 4-phenylbutyrate in epidermolysis bullosa: Lessons for therapies in keratin disorders.
    Spörrer M; Prochnicki A; Tölle RC; Nyström A; Esser PR; Homberg M; Athanasiou I; Zingkou E; Schilling A; Gerum R; Thievessen I; Winter L; Bruckner-Tuderman L; Fabry B; Magin TM; Dengjel J; Schröder R; Kiritsi D
    EBioMedicine; 2019 Jun; 44():502-515. PubMed ID: 31078522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in KRT5 and KRT14 cause epidermolysis bullosa simplex in 75% of the patients.
    Bolling MC; Lemmink HH; Jansen GH; Jonkman MF
    Br J Dermatol; 2011 Mar; 164(3):637-44. PubMed ID: 21375516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease severity correlates with position of keratin point mutations in patients with epidermolysis bullosa simplex.
    Letai A; Coulombe PA; McCormick MB; Yu QC; Hutton E; Fuchs E
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3197-201. PubMed ID: 7682695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A keratin 14 'knockout' mutation in recessive epidermolysis bullosa simplex resulting in less severe disease.
    Batta K; Rugg EL; Wilson NJ; West N; Goodyear H; Lane EB; Gratian M; Dopping-Hepenstal P; Moss C; Eady RA
    Br J Dermatol; 2000 Sep; 143(3):621-7. PubMed ID: 10971341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.